It is structurally related to [[papaverine]], is a selective [[Phosphodiesterase-4 inhibitor|inhibitor of phosphodiesterase 4]], and has no [[anticholinergic]] effects.<ref name="drugbank">{{cite web|title=The DrugBank database: Drotaverine|url=http://www.drugbank.ca/drugs/DB06751|website=DrugBank Version 4.1|publisher=The Metabolomics Innovation Centre|accessdate=9 August 2014}}</ref>

 
An article from 2013 described the effects from overdose (in a 19-year-old woman) as including vomiting, seizures and fatal cardiac toxicity.<ref>[https://link.springer.com/article/10.1007/s40278-013-7608-3 Drotaverine overdose (case report)] ''Reactions Weekly'', Volume 1481 (1), page 17.</ref>
